PTK7 and neoplasm: Translational and clinical studies support the implication of PTK7 in tumor development and metastatic dissemination and its suitability as a new therapeutic target using antibody-based strategies, antibody-drug conjugates (ADCs), and chimeric antigen receptor-modified T cells (CAR-T cells).